RecruitingNCT04123314
Study of psilocybin for depression with mild cognitive impairment or early Alzheimer’s disease
About this title
Read the official source — NCT04123314Medication studyAges 18–85United States
Understand this study
Who could participate?
Listed age limits: 18 years to 85 years.
What will I do during this study?
You take part in an eight-week open-label study with weekly psychological support and two psilocybin sessions, in weeks four and six. The study includes follow-up assessments for up to six months after the second session.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Number of visits
- 2 psilocybin sessions are planned in weeks 4 and 6, with weekly psychological support during an 8-week study.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 24, 2021
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 20
- Sponsor
- Johns Hopkins University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 85 Years
- Official registry ID
- NCT04123314
- Official title
Show the full official title
Pilot Study of Serotonin 2A Receptor (5-HT2A) Agonist Psilocybin for Depression in Patients With Mild Cognitive Impairment or Early Alzheimer's Disease
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Johns Hopkins University, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
Listed age limits: 18 years to 85 years.
Is this study still recruiting?
The registry lists this study as recruiting.
